JULIANN GEE: Open Payments
NPI 1841067568 · CINNAMINSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,322 in 81 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $853 · 2025 $1,322
Food & beverage: $1,222Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $399 |
| GENZYME CORPORATION | 6 | $188 |
| Organon LLC | 14 | $175 |
| UCB, Inc. | 13 | $168 |
| Janssen Biotech, Inc. | 1 | $100 |
| PFIZER INC. | 3 | $57 |
| Amgen Inc. | 3 | $47 |
| Lilly USA, LLC | 2 | $40 |
| Galderma Laboratories, L.P. | 2 | $35 |
| LEO Pharma Inc. | 2 | $32 |
Products named: SKYRIZI, DUPIXENT, Bimzelx, TREMFYA, VTAMA, CIBINQO, OTEZLA, TALTZ.
Industry payments across NJ — which companies pay providers there.
